NewsRoom Articles - Page 1321 of 1389

WednesdayJan 18, 2017 1:14 pm

Medical Transcription Billing, Corp. (NASDAQ: MTBC) Reflects on 2016 Milestones, Highlights 2017 Objectives

Leading health care information technology company Medical Transcription Billing, Corp. (NASDAQ: MTBC; MTBCP) this morning issued a news release recapping its corporate accomplishments for 2016, as well as its objectives for the coming months. Among last year’s highlights, MTBC continued to employ a tactical acquisition-based growth strategy, added important new clients in major markets across the country, recorded strong financial results and earned numerous prestigious accolades for its innovative health care information technology solutions. In an effort to rapidly expand its client base, MTBC completed four vital acquisitions in 2016, including the purchase of Texas-based medical billing company MediGain, LLC.…

WednesdayJan 18, 2017 9:50 am

Mounting Support for Marijuana Banking Has Widespread Implications

Although 28 states have already legalized marijuana for medicinal or recreational use, the U.S. Drug Enforcement Administration (DEA) continues to label marijuana a Schedule 1 substance, along with heroin and LSD, making it illegal on a federal level. As a result, the banking industry has been slow to provide services to marijuana businesses, forcing many of these companies to operate on a cash-only basis. A "bankable" marijuana industry, however, would have widespread implications, including for companies like Singlepoint, Inc. (OTC: SING), Terra Tech Corp. (OTCQX: TRTC), OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ChineseInvestors.com, Inc. (OTCQB: CIIX). Cash transaction businesses are…

WednesdayJan 18, 2017 9:12 am

From CytoDyn Inc. (CYDY), A Hope to Prevent HIV from Progressing into AIDS with Pro-140

HIV/AIDS may not be as much in the news as it was back in the 1980s, but the disease has not gone away. According to the Centers for Disease Control and Prevention (CDC) (http://nnw.fm/7yEVU), it still affects ‘more than 1.2 million people in the US… and 1 in 8 of them don't know it’. Although, perennially lumped together, HIV and AIDS are not synonymous. Not all those infected with HIV (HIV positive) have AIDS (acquired immunodeficiency syndrome), which is the final stage of HIV infection. The goal of antiretroviral therapy, or ART, has been to stop that progression, and that…

TuesdayJan 17, 2017 6:00 pm

ChineseInvestors.com, Inc. (CIIX) is “One to Watch”

ChineseInvestors.com (OTCQB: CIIX) is a leading financial information website for Chinese-speaking investors in the United States and China. Taking advantage of mounting interest in the Chinese nutrition and health products market, CIIX is also launching the world's first online cannabidiol (CBD) health products store published in the Chinese language. CIIX provides a range of investor education products and services, including real-time market commentary, analysis and education-related services in Chinese language character sets; consultative services to smaller private companies considering becoming public companies; and advertising and public relation-related support services. These services bode well for the company as it invests its…

TuesdayJan 17, 2017 3:17 pm

Moxian, Inc. (NASDAQ: MOXC) Targeting Chinese O2O Market and its Projected 20% Year-Over-Year Growth

Moxian, Inc. (NASDAQ: MOXC) is positioning itself as a leader in China’s O2O services market as the sector enjoys a 20% surge in year-over-year growth. iResearch Consulting Group, in its ‘2015 China Online-to-Offline (O2O) Services Model Research Report’ published in January 2016 (www.iresearchchina.com), stated that the Chinese O2O market was on course to grow from $53.78 billion in 2015, to $68.71 billion in 2016. The report also forecast growth of 20% year-over-year through 2018 to more than $90 billion (http://nnw.fm/Jyj1C). The reason for the quick growth is a high level of usage of the online services sector. Tencent Penguin Intelligence’s…

TuesdayJan 17, 2017 12:40 pm

An Update on Axsome Therapeutics, Inc. (NASDAQ: AXSM)

Once New York-based Axsome Therapeutics, Inc. (NASDAQ: AXSM) was founded in 2012, its team set out to establish a fully-integrated biopharmaceutical business that would develop therapies to treat and manage central nervous system (CNS) disorders. Now in 2017, the Axsome team is setting off on another exciting leg on this journey. For years, Axsome has been laser-focused on improving the lives of patients living with pain and various CNS disorders. With an eye toward differentiated therapies, the company has concentrated on developing and commercializing both in-licensed drug candidates and internally-derived drug candidates in order to accomplish its goal of increasing…

TuesdayJan 17, 2017 11:54 am

National Waste Management Holdings, Inc. (NWMH) Turns Trash into Treasure, Records Strong Revenue Growth

National Waste Management Holdings, Inc. (OTC: NWMH) has turned the old aphorism 'garbage in - garbage out' on its head. It’s now 'garbage in, revenues up'. In its last 10-Q filing, for the third quarter ended September 30, 2016, the company reported quarterly revenues of $1.8 million, which represented a 269 percent increase over 2015 same period revenues. This stellar performance in the third quarter boosted revenues in the nine-month period ended September 30, 2016, to $4.9 million, up by 262 percent over same period revenues for 2015. Not all garbage, it seems, is waste. National Waste operates a licensed…

TuesdayJan 17, 2017 9:24 am

Lomiko Metals, Inc. (LMRMD, LMRMF) Offers One of the Brightest Potentials in Mining and Materials

Lomiko Metals (OTCQB: LMRMD) (OTC: LMRMF) has positioned itself on top of an extremely positive supply-demand curve, with a unique opportunity for low-cost production of a key mineral that underpins much of the growing green economy. Lomiko’s core focus is on the exploration and development of minerals such as lithium and graphite, the latter of which is used for energy storage in products such as lithium-ion batteries, especially those used for electric vehicles (EV), and for which there is no cheaper alternative. The demand for EVs is expected to see rapid growth for at least the next 20 years, and…

FridayJan 13, 2017 2:54 pm

Medical Transcription Billing, Corp. (NASDAQ: MTBC) Award Recognizes Best Use of Proprietary Technologies

A growing number of health care professionals and medical practices are resorting to electronic management technologies, ranging from electronic health records to revenue cycle management, practice management and scheduling software and more. As a leading provider of integrated health care technologies, New Jersey-based Medical Transcription Billing, Corp. (NASDAQ: MTBC; MTBCP) is leveraging its proprietary technology to serve a wide range of health care customers across 40+ states, currently offering one of the most comprehensive suites of practice management, electronic health records and revenue cycle solutions on the market. Already serving hundreds of customers, the company traditionally recognizes the efforts of…

FridayJan 13, 2017 1:29 pm

DelMar Pharmaceuticals (NASDAQ: DMPI) Given a ‘Buy’ Rating and $16 Price Target by Aegis Capital

Biotechnology company DelMar Pharmaceuticals (NASDAQ: DMPI) has been given a ‘Buy’ rating by Aegis Capital Corp. and a $16 price target (http://nnw.fm/wWJH9). The company was trading at $3.29 on January 11, 2016. To reach that price target, Aegis, in its initiation of coverage, said that it applied a 15x multiple after estimating the company’s 2022 EPS at $3.93, then discounting it by 30%. DelMar Pharmaceuticals has been developing its lead product candidate, VAL-083, as a chemotherapy for cancer. Specifically, VAL-083 would be used in the treatment of glioblastoma multiforme (GBM), the most common form of a fatal and aggressive brain…

Financial news and publishing for public and private companies

Contact us: 512.354.7000